1. Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria;
2. AOP Orphan Pharmaceuticals AG, Vienna, Austria;
3. Sozialmedizinisches Zentrum Ost - Donauspital, Vienna, Austria;
4. Krankenhaus der Elisabethinen Linz, Linz, Austria;
5. Department of Internal Medicine IV, Wels-Grieskirchen Hospital, Wels, Austria;
6. Third Medical Department, Hanusch Hospital, Vienna, Austria;
7. Department of Internal Medicine V, Hematology & Oncology, Innsbruck Medical University, Innsbruck, Austria;
8. Medical Clinic 3, Oncology, Hematology and Rheumatology, University Hospital of Bonn, Bonn, Germany;
9. Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;
10. Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; and
11. Advanced Drug and Device Services SAS, Brno, Czech Republic